Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

November 30, 2024

Conditions

Parkinson's DiseaseParkinson

Interventions

BEHAVIORAL

Ketoflex 12/3 Diet

A plant-based ketogenic diet combined with intermittent fasting (12/3)

Trial Locations (1)

İstanbul Medipol Üniversitesi, Istanbul

All Listed Sponsors

lead

Istanbul Medipol University Hospital

OTHER

NCT06892418 - Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study | Biotech Hunter | Biotech Hunter